{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-051276","form_type":"8-K","ticker":"RNLXY","cik":"0001811115","company_name":"Renalytix plc","filed_at":"2023-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.589509+00:00","generated_at":"2026-06-10T05:36:12.141752+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CMS sets Medicare price for Renalytix's kidneyintelX.dkd test at $950, effective Jan 2024","bullets":["CMS published price for FDA-authorized kidneyintelX.dkd test on national Clinical Lab Fee Schedule at $950.","Pricing effective Jan 1, 2024 and maintained for a minimum of three years.","AMA panel recommended a new CPT code to differentiate kidneyintelX.dkd from the original LDT, triggering the pricing review.","Company states the CMS action affirms KidneyIntelX platform value and aids in expanding insurance coverage."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-051276","json":"https://secwatch.observer/filing/0000950170-23-051276.json","markdown":"https://secwatch.observer/filing/0000950170-23-051276.md","text":"https://secwatch.observer/filing/0000950170-23-051276.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811115/000095017023051276/0000950170-23-051276-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811115/000095017023051276/rnlx-20231003.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T05:36:12.141752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}